Donald Trump Usa India covid-19 testing patient Donald Trump Usa India

As global demand for HCQ rises, Indian pharma firms to keep huge buffer stock

Reading now: 103
www.livemint.com

Drug makers have promised to keep a minimum buffer stock of 100 million tablets of chloroquine tablets and HCQ India’s pharmaceutical industry has assured the government it will be able to comfortably meet the domestic needs for hydroxychloroquine after exporting to the US and other overseas buyers, industry executives said.

The malaria drug is touted by some—most famously US President Donald Trump—as a potential cure for covid-19, although there is only anecdotal evidence for it.

Putting at rest fears that India could run short of the drug, pharmaceutical firms have promised that they will keep a minimum buffer stock of 100 million tablets of chloroquine and its safer derivative hydroxychloroquine before exporting any. “Production is

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA